Article
Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A.
PLoS pathogens - 1 Feb 2017
Velázquez-Moctezuma Rodrigo, Law Mansun, Bukh Jens, Prentoe Jannick
Abstract excerpt
Hepatitis C virus (HCV) is a major cause of end-stage liver diseases. With 3-4 million new HCV infections yearly, a vaccine is urgently needed. A better understanding of virus escape from neutralizing antibodies and their corresponding epitopes are important for this effort. However, for viral isolates with high antibody resistance, or antibodies with moderate potency, it remains challenging to induce escape...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
